Treatment Guide

Blue Light Therapy: What It Treats and What the Evidence Shows

Blue light therapy is used for acne, precancerous skin spots and winter depression. A 2022 review of 9 trials found its benefit for depression still unproven.

Mental Health Stats Research Team 8 min read

Key Takeaways

  • Blue light therapy uses visible light in the 400 to 500 nm range, which carries no ultraviolet radiation[1].400–500 nm[1]
  • A 2022 meta-analysis of 9 randomized trials (347 participants) found the efficacy of blue light for seasonal and non-seasonal depression unproven[2].9 RCTs[2]
  • A 2025 network meta-analysis of 17 trials (773 patients) ranked white light first for seasonal affective disorder, followed by green, blue and red light[3].17 RCTs[3]
  • For acne, a 2019 meta-analysis of 14 trials (698 participants) found no significant difference in inflammatory or non-inflammatory lesion counts with blue light[4].14 RCTs[4]
  • The FDA-approved use is photodynamic therapy for actinic keratoses: a light-sensitizing drug followed by blue light from the BLU-U illuminator[5].FDA label[5]
  • In a 2019 test of 24 light therapy devices sold for depression, only 7 met three basic clinical criteria[6].7 of 24[6]

What Is Blue Light Therapy?

Blue light therapy is treatment with visible light in the 400 to 500 nm band, a UV-free form of phototherapy[1]. The same name covers two unrelated practices: shining blue light on the skin to treat acne and precancerous lesions, and shining light into the eyes to treat mood symptoms linked to mental illness such as seasonal affective disorder.

The skin uses rest on chemistry in the skin itself. Blue light excites porphyrins, light-absorbing compounds that generate reactive oxygen species, and reaches a maximum depth of about 0.07 to 1 mm[1].

The mood use works through the eye. The retinal pigment melanopsin absorbs light most strongly near 480 nm and activates retinal cells that project to the suprachiasmatic nucleus, the body's master circadian clock[6]. Light boxes for depression are therefore measured in lux, the brightness reaching the eye at a set distance, rather than by dose delivered to the skin[6].

This article covers what blue light treatments are used for and what trials found. For how common seasonal depression is, see the seasonal affective disorder statistics page.

Photodynamic therapy (PDT)

A two-step treatment in which a light-sensitizing drug is applied to the skin and later activated with light. In the FDA-approved blue light version, aminolevulinic acid is applied to actinic keratoses and illuminated with the BLU-U Blue Light Photodynamic Therapy Illuminator after an incubation period[5].

Related Terms

ALA-PDT
aminolevulinic acid
actinic keratosis
phototherapy

Source: U.S. Food and Drug Administration prescribing information, 2018

What Is Blue Light Therapy Used For?

The one use with FDA approval is photodynamic therapy for actinic keratoses, rough precancerous patches caused by sun damage. The label covers minimally to moderately thick lesions of the face or scalp and lesions of the upper extremities[5].

Blue light alone, without a drug, is marketed for mild to moderate acne. Its proposed action is reducing follicular colonization by the acne bacterium Propionibacterium acnes[1].

Researchers have also tested blue light for atopic dermatitis, eczema and psoriasis because of its anti-inflammatory and antiproliferative effects, though the authors of a 2021 review say accurate treatment protocols still need to be developed[1]. On the mental health side, blue and blue-enriched light have been studied for seasonal and non-seasonal major depressive disorder[2].

Blue Light Therapy: Evidence at a Glance

UseBest evidenceMain findingYear
Actinic keratosis (with ALA)FDA-approved drug-device labelApproved for face, scalp and upper extremities2018
Acne (blue light alone)Meta-analysis, 14 RCTs (698)No significant change in lesion counts2019
Acne (all light therapies)Cochrane review, 71 RCTs (4,211)High-quality evidence lacking2016
Seasonal and non-seasonal depressionMeta-analysis, 9 RCTs (347)Efficacy unproven2022
Seasonal affective disorderNetwork meta-analysis, 17 RCTs (773)White light ranked above blue2025

Highest-level evidence found for each use of blue light therapy, by condition and year of publication[5][4][7][2][3].

1RCT = randomized controlled trial. Numbers in parentheses are total participants across pooled trials.

Sources

  • •FDA, 2018
  • •Scott et al., Annals of Family Medicine, 2019
  • •Barbaric et al., Cochrane, 2016
  • •Do et al., Canadian Journal of Psychiatry, 2022
  • •Medicine (Baltimore), 2025

Does Blue Light Therapy Work for Depression and Seasonal Affective Disorder?

Not clearly, based on pooled trials. A 2022 meta-analysis in The Canadian Journal of Psychiatry included 9 randomized trials with 347 participants, 7 of them in seasonal major depression and 2 in non-seasonal major depression[2].

Against inactive light conditions, blue light showed no evidence of efficacy (mean difference 2.43; 95% CI, −1.28 to 6.14)[2]. Against active light conditions, it showed no difference either (mean difference −0.11; 95% CI, −2.38 to 2.16), and response and remission rates did not differ significantly[2]. The authors concluded that efficacy remains unproven and called for longer, larger trials with standardized light parameters[2].

A 2025 network meta-analysis of visible light for seasonal affective disorder pooled 17 trials with 773 patients: 14 tested white light, 6 blue, 2 green and 5 red[3]. It ranked white light as most effective, followed by green, blue and red, and concluded that white light may be the best visible light therapy for the condition[3].

Why blue light was expected to help

The circadian system is especially sensitive to short (blue-appearing) and middle (green-appearing) wavelengths[6]. Placebo-controlled trials of LED devices for seasonal affective disorder have reported efficacy for 398-lux and 200-lux narrow-band blue light, far dimmer than a standard light box[6].

Those small positive trials have not added up to a clear advantage in pooled analyses. A 2019 device study in an American Psychiatric Association journal stated that there is no evidence treatment efficacy is greater with short-wavelength light than with adequate broad-spectrum white light[6].

How standard light therapy compares

The standard treatment for winter-pattern seasonal affective disorder is a white light box of 10,000 lux used for about 30 to 45 minutes each morning from fall to spring, according to NIMH[8]. NIMH lists light therapy and vitamin D as treatments for winter-pattern SAD, and psychotherapy and antidepressants for depression generally[8].

Bright white light has stronger pooled evidence than blue light. A 2025 JAMA Psychiatry meta-analysis of 11 trials (858 patients) found remission in 40.7% of patients with non-seasonal depression given bright light therapy as an add-on treatment, versus 23.5% of controls[9]. Other add-on and first-line options are covered in cognitive behavioral therapy for depression.

Randomized trials pooled in the 2022 meta-analysis of blue-light therapy for depression (347 participants)
9 trials

Blue light was neither better than inactive light nor different from active light conditions, and the authors judged its efficacy for seasonal and non-seasonal depression unproven.

"The efficacy of blue-light therapy in the treatment of seasonal and non-seasonal MDD remains unproven."

The Canadian Journal of Psychiatry(2022) View Source
How to read these trial results: A mean difference compares depression scale scores between groups, and a confidence interval that crosses zero means the trials could not rule out no effect. A finding of "no difference from active light" in small trials does not show that blue light and white light work equally well; it means the studies were too small or too varied to detect a difference. Most blue light trials had small samples, and the 2022 review called for longer and larger studies[2].

Does Blue Light Therapy Work for Acne?

The evidence is weak. A 2019 meta-analysis in the Annals of Family Medicine included 14 randomized trials with 698 participants, most of them small, shorter than 12 weeks and at high risk of bias[4].

Pooled across trials, blue light did not significantly change non-inflammatory lesion counts (mean difference 3.47; 95% CI, −0.76 to 7.71) or inflammatory lesion counts (mean difference 0.16; 95% CI, −0.99 to 1.31)[4]. Three of 5 trials that measured investigator-assessed improvement reported significantly greater improvement with blue light[4].

The authors described blue light's likely role as secondary to first-line treatments such as topical benzoyl peroxide, with possible use as an alternative to oral antibiotics[4]. A 2016 Cochrane review of all light therapies for acne, covering 71 trials and 4,211 participants, found high-quality evidence lacking and low certainty about blue light photodynamic therapy as a standard treatment for moderate to severe acne[7].

Blue Light Photodynamic Therapy for Actinic Keratosis

Blue light photodynamic therapy pairs a topical aminolevulinic acid solution with the BLU-U illuminator. The FDA label calls for illumination 14 to 18 hours after application for face or scalp lesions and 3 hours after application, with occlusion, for upper-extremity lesions[5].

A 10 J/cm² light dose requires a 1,000-second exposure, or 16 minutes 40 seconds[5]. Treatment may be repeated once for lesions that have not completely resolved after 8 weeks[5].

The drug is contraindicated in people with skin photosensitivity at 400 to 450 nm, porphyria or allergy to porphyrins[5]. The label lists St. John's wort, griseofulvin, thiazide diuretics, sulfonylureas, phenothiazines, sulfonamides and tetracyclines as drugs that might increase the photosensitivity reaction[5].

Blue Light Therapy vs. Red Light Therapy

The main physical difference is depth. Blue light penetrates skin more superficially than red light, so only red light is used to treat skin cancers, while blue light may be used for non-hyperkeratotic actinic keratosis[1].

In acne, both colors are used to activate photodynamic drugs: MAL-PDT with red light and ALA-PDT with blue light[7]. The Cochrane review rated the evidence for both as low certainty[7]. Red and near-infrared light used without a drug is a separate field, covered in low-level laser (red and near-infrared) therapy.

In mood research, red light usually serves as the placebo. The 2025 network meta-analysis noted that red light has a strong placebo effect in seasonal affective disorder trials and treated it as a comparison condition rather than an active intervention[3].

Blue Light Therapy Side Effects and Eye Safety

Side effects depend on the type of treatment. With photodynamic therapy, the most common reactions occurring in at least 10% of patients include redness, swelling, stinging or burning, scaling, itching and pigment changes[5].

In the face and scalp trials, at least 50% of subjects reported severe stinging or burning at one or more lesions during light treatment[5]. Redness shortly after treatment occurred in 99% of the active group and 79% of the vehicle group, and swelling in about 35% versus under 1%[5].

Blue light alone is milder. Adverse events in acne trials were generally mild[4], and blue light for depression was overall well tolerated[2]. A 2021 dermatology review noted that no study has examined the long-term effects of blue light on skin[1].

Eye safety

Light boxes for depression are aimed at the eyes, so wavelength matters. A 2019 analysis of 24 consumer devices found one emitting deep-blue light peaking at 413 nm, which had the worst ratio of therapeutic potential to retinal hazard of any device tested[6]. The authors wrote that devices emitting high levels of short-wavelength light may pose unnecessary risk to the retina[6].

Only 7 of the 24 devices met the study's criteria for adequate brightness, coverage and glare, and some devices sold as "10,000-lux" reached that level only at unreasonably close distances[6]. NIMH notes that people with certain eye diseases, or who take medications that increase sensitivity to sunlight, may need alternative treatments or medical supervision for light therapy[8].

Light exposure also shifts sleep timing, which links light treatment to circadian rhythm disorders. Some research summarized in the 2025 network meta-analysis suggests blue light exposure at night may increase the risk of depression, the opposite of the daytime therapeutic aim[3].

Frequently Asked Questions

Sources & References

  1. Sadowska M, Narbutt J, Lesiak A. Blue light in dermatology. Life. Published 2021. Accessed October 2026. https://doi.org/10.3390/life11070670 [Link]
  2. Do A, Li VW, Huang S, et al. Blue-light therapy for seasonal and non-seasonal depression: a systematic review and meta-analysis of randomized controlled trials. The Canadian Journal of Psychiatry. Published 2022. Accessed October 2026. https://doi.org/10.1177/07067437221097903 [Link]
  3. Effectiveness of visible light for seasonal affective disorder: a systematic review and network meta-analysis. Medicine (Baltimore). Published 2025. Accessed October 2026. https://doi.org/10.1097/MD.0000000000043107 [Link]
  4. Scott AM, Stehlik P, Clark J, et al. Blue-light therapy for acne vulgaris: a systematic review and meta-analysis. Annals of Family Medicine. Published 2019. Accessed October 2026. https://doi.org/10.1370/afm.2445 [Link]
  5. U.S. Food and Drug Administration. Levulan Kerastick (aminolevulinic acid HCl) for topical solution: prescribing information. Published 2018. Accessed October 2026. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020965s015lbl.pdf [Link]
  6. Oldham MA, Oldham MB, Desan PH. Commercially available phototherapy devices for treatment of depression: physical characteristics of emitted light. Psychiatric Research and Clinical Practice. Published 2019. Accessed October 2026. https://doi.org/10.1176/appi.prcp.2019.20180011 [Link]
  7. Barbaric J, Abbott R, Posadzki P, et al. Light therapies for acne. Cochrane Database of Systematic Reviews. Published 2016. Accessed October 2026. https://doi.org/10.1002/14651858.CD007917.pub2 [Link]
  8. National Institute of Mental Health. Seasonal affective disorder. National Institutes of Health. Published 2023. Accessed October 2026. https://www.nimh.nih.gov/health/publications/seasonal-affective-disorder [Link]
  9. Menegaz de Almeida A, Aquino de Moraes FC, Cavalcanti Souza ME, et al. Bright light therapy for nonseasonal depressive disorders: a systematic review and meta-analysis. JAMA Psychiatry. Published 2025. Accessed October 2026. https://doi.org/10.1001/jamapsychiatry.2024.2871 [Link]

Related Statistics